Dr.Dharmar Manimaran

@tanuvas.ac.in

Post Doctoral Fellow (PDF),Department of Animal Nutrition,Veterinary College and Research Institute,Tamil Nadu Veterinary and Animal Sciences University,Namakkal-637 002,Tamil Nadu,India
Tamil Nadu Veterinary and Animal Sciences University

Dr.Dharmar Manimaran

EDUCATION

Doctor of philosophy in Biotechnology

RESEARCH INTERESTS

Nanomedicine, Neuroscience, Cancer Biology, Toxicology
13

Scopus Publications

386

Scholar Citations

8

Scholar h-index

8

Scholar i10-index

Scopus Publications

  • A Novel Peptide HIF9-Nano Complex Targeting Apoptosis in Breast Cancer Cells via Modulating HIF Alpha Signaling Cascades
    Dharmar Manimaran, Vasan Palanisamy, Kowsalya Rangasamy, Namasivayam Elangovan
    International Journal of Peptide Research and Therapeutics, 2025
  • Current Perspectives in Detection of Bioactive Compounds From Costus spicatus Through GC–MS and LC-MS/MS: Antioxidant Properties and In Silico Analysis for Industrial Applications
    Dharmar Manimaran, Ararsa Tessema, M. Govindarajulu Yadav, S. Parthasarathi, Vasan Palanisamy
    Biochemistry Research International, 2025
    Members of the Costus genus are the conventional medicinal plants used in the therapeutic management of numerous ailments, especially for their antioxidant and pharmacological activities. The crude extract of Costus spicatus was profiled using high‐resolution GC–MS and LC‐MS/MS techniques to determine possible bioactive compounds that are vital to the antioxidant activity. A total of 52 and 63 bioactive compounds have been detected in GC–MS chromatograms using different solvents (methanol and ethanol) in C. spicatus leaf extracts, representing the presence of certain bioactive compounds. The identified bioactive compounds in both extracts which exhibit neuroprotective effects have been confirmed through various literature studies. They are cholestan‐3‐amine, loliolide, stigmasterol and methylprednisolone acetate, succinimide, fumaric acid, beta‐tocopherol and gamma‐tocopherol. The aqueous extract possessed the highest antioxidant activity for DPPH scavenging activity and lipid peroxidation inhibition assays, whereas the alcoholic aqueous extract showed superior efficacy for hydroxyl radical scavenging activity. In this study, we performed molecular docking and found that four compounds exhibited promising binding affinities with predicted binding sites on alpha‐synuclein. Notably, Androsta [17‐16‐b] furan‐5′‐imine, 4′‐methylene‐3‐methoxy‐N‐cyclohexyl‐ showed the highest docking interaction score of −7.4, indicating a strong binding affinity. These findings, combined with the presence of bioactive components in the crude extract of C. spicatus, suggest that this plant may possess neuroprotective properties, warranting further investigation for potential industrial applications in the development of neuroprotective agents.
  • Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type
    Dharmar Manimaran, Namasivayam Elangovan, Vasan Palanisamy
    Jordan Journal of Pharmaceutical Sciences, 2024
    Over the past decade, personalized medicine has acquired considerable attention, emerging as a promising avenue for enhancing cancer treatment and therapy. Within this rapidly increasing field, the latest research introduces an innovative approach focused on a nano-formulated peptide, HIF-alpha, distinguished by its unique dual pharmacological potential. Various tumor-induced rat model has been undertaken to assess the peptide's efficacy in combatting DMBA-induced breast cancer. The findings clearly demonstrate the synthesized peptide's profound impact on various feature of tumor biology, including the proliferation of malignant cells, the synthesis of fatty acids crucial for cellular metabolism, and the regulation of lactate levels implicated in tumor progression. Histopathological analyses provide compelling evidence of the peptide's ability to established multifaceted pharmacological effects within the tumor microenvironment. Moreover, it has been demonstrated that regulatory influence on key membrane receptors, namely HER2 and EGFR, further underscores its therapeutic promise. In summary, the peptide HIF-alpha emerges as a potential landmark, offering a more efficacious therapeutic adjunct to existing medications, irrespective of the malignancy's stage. This innovative discovery holds transformative potential in reshaping conventional cancer treatment paradigms, heralding a new era of precision medicine in oncology.
  • PIASA, A Novel Peptide, Prevents SH-SY5Y Neuroblastoma Cells against Rotenone-induced Toxicity
    Elangovan Namasivayam, Ahmed Sha Sulthana, Rengasamy Balakrishnan, Mani Renuka, Thangavel Mohankumar, et al.
    Current Molecular Pharmacology, 2023
    Background and Objective: This investigation explores the neuroprotective effect of PIASA, a newly designed peptide, VCSVY, in in-silico and in opposition to rotenone stimulated oxidative stress, mitochondrial dysfunction, and apoptosis in an SH-SY5Y cellular model. Methods: Docking and visualization of the PIASA and rotenone were progressed against mitochondrial respiratory complex I (MCI). The in-silico analysis showed PIASA to have interaction with the binding sites of rotenone, which may reduce the rotenone interaction and its toxicity too. The SH-SY5Y cells were segregated into four experimental groups: Group I: untreated control cells; Group II: rotenone-only (100 nM) treated cells; Group III: PIASA (5 μM) + rotenone (100 nM) treated cells; and Group IV: PIASA-only (5 μM) treated cells. Results: We evaluated the cell viability, mitochondrial membrane potential (MMP), reactive oxygen species (ROS), apoptosis (dual staining technique), nuclear morphological changes (Hoechst staining technique), the expressions of BAX, Bcl-2, cyt c, pro-caspase 3, and caspase 3, -6, -8, -9, and cleaved caspase 3 by western blot analysis. In SH-SY5Y cells, we further observed the cytotoxicity, oxidative stress and mitochondrial dysfunction in rotenone-only treated cells, whereas pretreatment of PIASA attenuated the rotenone-mediated toxicity. Moreover, rotenone toxicity is caused by complex I inhibition, which leads to mitochondrial dysfunction, increased BAX expression, while downregulating the Bcl-2 expression and cyt c release, and then finally, caspases activation. PIASA pretreatment prevented the cytotoxic effects via the normalization of apoptotic marker expressions influenced by rotenone. In addition, pre-clinical studies are acceptable in rodents to make use of PIASA as a revitalizing remedial agent, especially for PD in the future. Conclusion: Collectively, our results propose that PIASA mitigated rotenone-stimulated oxidative stress, mitochondrial dysfunction, and apoptosis in rotenone-induced SH-SY5Y cells.
  • Isolongifolene-loaded chitosan nanoparticles synthesis and characterization for cancer treatment
    Dharmar Manimaran, Namasivayam Elangovan, Panagal Mani, Kumaran Subramanian, Daoud Ali, et al.
    Scientific Reports, 2022
    Recent breakthroughs in the field of nanoparticle-based therapeutic delivery methods have changed the standpoint of cancer therapy by effectively delaying the process of disease development. Nanoparticles have a unique capacity of good penetrating ability than other therapeutic leads used in traditional therapeutics, and also, they have the highest impact on disease management. In the current study isolongifolene-loaded Chitosan nanoparticles have been formulated, synthesized and then characterized by the use of Fourier Transform Infrared Spectroscopy, X-ray Diffraction, Scanning Electron Microscopy and Transmission Electron Microscopy. Further, the characterized chitosan nano formulation was evaluated for hemocompatibility, plasma stability, and in-vitro release. Isolongifolene-loaded chitosan nanoparticles were found to be compatible with plasma and also, they exhibited a constant release pattern. Hence, chitosan-loaded nanoparticles could be employed as an excellent adjuvant in cancer therapeutic, to combat the multi-drug resistance in solid tumors.
  • miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer
    Durairaj Sekar, Mani Panagal, Dharmar Manimaran, Naushad Ahmad, Tentu Nageswara Rao, et al.
    Oral Oncology, 2022
  • Exposure to 7, 8 Dihydroxycoumarin protects Cadmium induced toxicity effect in Zebrafish (Daniorerio) embryos
    Manimaran Dharmar, Renuka Varatharajan, Ramesh Saravanan, Govarthanan Kavitha, Elangovan Namasivayam
    Research Journal of Chemistry and Environment, 2022
    Cadmium (Cd) is one of the precedence pollutants in the environment which menaces the aquatic organisms. Cd is also shown to have deleterious health impairments causing male and female infertility in humans. In this study, we investigated the role of 7, 8- DHC as a potent rescuer of Cd induced toxicity using zebrafish (Daniorerio) model. The anti-oxidant property of 7,8-DHC was analysed and confirmed using 2,2-diphenyl-1-picrylhydrazyl (DPPH), ferric ion reducing power (FRAP) and hydroxyl radical (OH) assays. Further, we induced Cd toxicity in zebrafish embryos at 100-μM concentration and the intoxicated embryos showed a significantly reduced survival, delayed hatching and phenotypic aberrations at 24, 48, 72 and 96 hours post fertilization (hpf). Similarly, Cd intoxicated embryos showed an expressively increased cardiac function (170 ±1 beats/min and 172± 1 beats/min) at 48 and 60 hpf. Furthermore, the rescuing effect of 7,8-DHC was analysed via treatment of Cd intoxicated embryos at dosage dependent manner. At 100 μg, 7,8-DHC showed significantly reduced heart beat compared to the Cd intoxicated embryos. Moreover, 50 and 100 μg of 7, 8-DHC treated groups showed 103± 1 beats/min and 104±1 beats/min respectively. Histopathological interpretations revealed the rescuing effects on notochordal segmentation at 50 and 100 μg 7, 8-DHC in Cd intoxicated embryos at 96 hpf. Overall, our results clinched that 7, 8-DHC could act as a potent redox scavenger against Cd toxicity.
  • Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease
    Rengasamy Balakrishnan, Dhanraj Vijayraja, Thangavel Mohankumar, Dharmar Manimaran, Palanivel Ganesan, et al.
    Journal of Chemical Neuroanatomy, 2021
  • Author Correction: Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein (Scientific Reports, (2020), 10, 1, (599), 10.1038/s41598-020-57417-9)
    Thangavel Mohankumar, Vivek Chandramohan, Haralur Shankaraiah Lalithamba, Richard L. Jayaraj, Poomani Kumaradhas, et al.
    Scientific Reports, 2020
    An amendment to this paper has been published and can be accessed via a link at the top of the paper.
  • Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein
    Thangavel Mohankumar, Vivek Chandramohan, Haralur Shankaraiah Lalithamba, Richard L. Jayaraj, Poomani Kumaradhas, et al.
    Scientific Reports, 2020
    Parkinson’s disease (PD) is the second most common neurodegenerative disorder caused due to loss of dopaminergic neurons in substantia nigra pars compacta, which occurs the presence of Lewy bodies made up of Alpha-synuclein (ASN) aggregation resulting in neuronal death. This study aims to identify potent 7,8-Dihydroxyflavone (DHF) derivatives to inhibit the ASN aggregation from in silico analysis. Molecular docking study reveals that carbamic ester derivatives of DHF [DHF-BAHPC (8q), DHF-BAHPEC (8s), DHF-BAHEC (8p), DHF-BDOPC (8c), DHF-BAPEC (8n) and DHF-BAMC (8h)] have good binding affinity towards ASN, when compared with DHF and L-DOPA; their docking score values are −16.3120, −16.1875, −15.2223, −14.3118, −14.2893, –14.2810, −14.0383, and −9.1560 kcal/mol respectively. The in silico pharmacological evaluation shows that these molecules exhibit the drug-likeness and ADMET properties. Molecular dynamics simulation confirms the stability of the molecules with ASN. The intermolecular interaction analyzed under the dynamic condition, allows to identify the candidate which potentially inhibits ASN aggregation. Hence, we propose that DHF derivatives are the potential lead drug molecules and preclinical studies are needed to confirm the promising therapeutic ability against PD.
  • Erythrosine Induces Teratogenic Effects Via Activation of ROS Biogenesis in Zebrafish Embryos
    Manimaran Dharmar, Nadhiya Krishnan, Mohankumar Thangavel, Manigandan Krishnan, Elangovan Namasivayam
    Iranian Journal of Science and Technology Transaction A Science, 2019
  • Molecular insights of newly identified potential peptide inhibitors of hypoxia inducible factor 1α causing breast cancer
    Dharmar Manimaran, Shanmugam Ghanendra, Menakha Sridhar, Jagatheesh Kaliaperumal, Sangeetha Muniyaraj, et al.
    Journal of Molecular Structure, 2019
  • Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis
    Krishnan Manigandan, Dharmar Manimaran, Richard L. Jayaraj, Namasivayam Elangovan, Velumani Dhivya, et al.
    Biochimie, 2015

RECENT SCHOLAR PUBLICATIONS

  • Peptide pACC1-Nano Complex Abrogates ACC1-Mediated Lipogenesis in Breast Cancer Cells Via Modulating p53/NF-κB Signaling Cascades
    D Manimaran, J Kaliaperumal, N Elangovan, V Palanisamy
    Journal of Bioengineering and Applied Biosciences 2 (1), 1-11 , 2026
    2026
  • Understanding the Pharmacokinetic Effect of Aspartame and Nateglinide Against Hydrolase: An Insilico Study
    VPKK Dharmar Manimaran, N.Somasundra Vengadase
    Jordan Journal of Pharmaceutical Sciences 3 (1), 32-39 , 2026
    2026
  • Peptide pACC1-nano complex suppresses ACC1-mediated lipogenesis 5 in breast cancer cells via altering p53/NF-κB pathway of signalling
    D Manimaran, V Palanisamy
    2025
  • A Novel Peptide HIF9-Nano Complex Targeting Apoptosis in Breast Cancer Cells via Modulating HIF Alpha Signaling Cascades
    D Manimaran, V Palanisamy, K Rangasamy, N Elangovan
    International Journal of Peptide Research and Therapeutics 31 (2), 15 , 2025
    2025
    Citations: 1
  • Research Article Current Perspectives in Detection of Bioactive Compounds From Costus spicatus Through GC–MS and LC-MS/MS: Antioxidant Properties and In Silico Analysis for …
    D Manimaran, A Tessema, MG Yadav, S Parthasarathi, V Palanisamy
    2025
  • Current Perspectives in Detection of Bioactive Compounds From Costus spicatus Through GC–MS and LC‐MS/MS: Antioxidant Properties and In Silico Analysis for …
    D Manimaran, A Tessema, MG Yadav, S Parthasarathi, V Palanisamy
    Biochemistry Research International 2025 (1), 9599942 , 2025
    2025
    Citations: 2
  • “Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type”
    MD Vasan Palanisamy., Namasivayam Elangovan
    Jordan Journal of Pharmaceutical Sciences 17 (4), 783–793 , 2024
    2024
    Citations: 4
  • Microbiology of Skin Disease and its Control through Herbal Drugs
    DM P. Navinraja,, Manickam Muthuselvam
    IOASD Journal of Medical and Pharmaceutical Sciences 1 (1), 34-37 , 2024
    2024
  • Embryonic Exposure to Sunset Yellow Induce Developmental Alterations and Oxidative Stress in Zebra Fish
    VPNE Dharmar Manimaran, C. Sivagami
    IOASD Journal of Medical and Pharmaceutical Sciences 1 (1), 85-92 , 2024
    2024
    Citations: 1
  • Synthesis, characterization and potential studies of peptide loaded chitosan coated (PLCC) and sodium alginate (SA) nanoparticles
    D Manimaran, V Palanisamy
    J Clin Chem Lab Med 7, 291 , 2024
    2024
    Citations: 3
  • Effect Of 7, 8 Dihydroxycoumarin Protects Environment Toxicity of Cadmium Induced in Zebrafish (Danio Rerio) Embryos
    D Manimaran, P Vasanthakumar, V Palanisamy
    Solid Waste 2023, 420 , 2023
    2023
  • Isolongifolene-loaded chitosan nanoparticles synthesis and characterization for cancer treatment
    D Manimaran, N Elangovan, P Mani, K Subramanian, D Ali, S Alarifi, ...
    Scientific Reports 12 (1), 19250 , 2022
    2022
    Citations: 40
  • miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer
    D Sekar, M Panagal, D Manimaran, N Ahmad, TN Rao, SY Alomar
    Oral oncology 129, 105873 , 2022
    2022
    Citations: 6
  • PIASA, A Novel Peptide, Prevents SH-SY5Y Neuroblastoma Cells against Rotenone-induced Toxicity
    AS Sulthana, R Balakrishnan, M Renuka, T Mohankumar, D Manimaran, ...
    Current molecular pharmacology , 2022
    2022
    Citations: 1
  • Exposure to 7, 8 Dihydroxycoumarin protects Cadmium induced toxicity effect in Zebrafish (Daniorerio) embryos
    KGNE Dharmar Manimaran, Varatharajan Renuka , Saravanan Ramesh
    Research Journal of Chemistry and Environment 26 (2), 14-22 , 2022
    2022
    Citations: 1
  • Evaluation of Nitrate Content in Water Samples of Dharmapuri District Meant for Livestock Feeding
    C Kathirvelan, D Manimaran
    2021
  • Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease
    R Balakrishnan, D Vijayraja, T Mohankumar, D Manimaran, P Ganesan, ...
    Journal of chemical neuroanatomy 112, 101890 , 2021
    2021
    Citations: 53
  • Assessment of nitrate content in green fodder samples of Salem District meant for livestock feeding
    DJVM C Kathirvelan, Dharmar Manimaran, P Vasanthakumar, S Banupriya
    Journal of Pharmacognosy and Phytochemistry 9 (3), 77-79 , 2020
    2020
  • Author Correction: Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein
    T Mohankumar, V Chandramohan, HS Lalithamba, RL Jayaraj, ...
    Scientific Reports 10, 5085 , 2020
    2020
    Citations: 2
  • Design and molecular dynamic investigations of 7, 8-dihydroxyflavone derivatives as potential neuroprotective agents against alpha-synuclein
    T Mohankumar, V Chandramohan, HS Lalithamba, RL Jayaraj, ...
    Scientific reports 10 (1), 599 , 2020
    2020
    Citations: 81

MOST CITED SCHOLAR PUBLICATIONS

  • Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis
    K Manigandan, D Manimaran, RL Jayaraj, N Elangovan, V Dhivya, ...
    Biochimie 119, 103-112 , 2015
    2015
    Citations: 109
  • Design and molecular dynamic investigations of 7, 8-dihydroxyflavone derivatives as potential neuroprotective agents against alpha-synuclein
    T Mohankumar, V Chandramohan, HS Lalithamba, RL Jayaraj, ...
    Scientific reports 10 (1), 599 , 2020
    2020
    Citations: 81
  • Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease
    R Balakrishnan, D Vijayraja, T Mohankumar, D Manimaran, P Ganesan, ...
    Journal of chemical neuroanatomy 112, 101890 , 2021
    2021
    Citations: 53
  • Isolongifolene-loaded chitosan nanoparticles synthesis and characterization for cancer treatment
    D Manimaran, N Elangovan, P Mani, K Subramanian, D Ali, S Alarifi, ...
    Scientific Reports 12 (1), 19250 , 2022
    2022
    Citations: 40
  • Reactive black 5 induced developmental defects via potentiating apoptotic cell death in Zerafish (Danio rerio) embryos.
    Dharmar Manimaran,Ahamad sha Sulthana, Namasivayam Elangovan
    Pharmacy & Pharmacology International Journal 6 (Issue 6 - 2018), 449-551 , 2018
    2018
    Citations: 26
  • Isolongifolene attenuates oxidative stress and behavioral impairment in rotenone-induced rat model of Parkinson’s disease
    R Balakrishnan, K Tamilselvam, A Sulthana, T Mohankumar, ...
    International Journal of Nutrition, Pharmacology, Neurological Diseases 8 (2 … , 2018
    2018
    Citations: 19
  • Molecular insights of newly identified potential peptide inhibitors of hypoxia inducible factor 1α causing breast cancer
    D Manimaran, S Ghanendra, M Sridhar, J Kaliaperumal, S Muniyaraj, ...
    Journal of Molecular Structure 1177, 558-563 , 2018
    2018
    Citations: 13
  • Erythrosine Induces Teratogenic Effects Via Activation of ROS Biogenesis in Zebrafish Embryos
    D Manimaran, K Nadhiya, T Mohankumar, K Manigandan, N Elangovan
    Iranian Journal of Science and Technology, Transactions A: Science, 1-9 , 2018
    2018
    Citations: 12
  • miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer
    D Sekar, M Panagal, D Manimaran, N Ahmad, TN Rao, SY Alomar
    Oral oncology 129, 105873 , 2022
    2022
    Citations: 6
  • Comparative analysis on Bioelectricity generation from Cow dung, vegetable and fishery waste using laboratory designed microbial fuel cell
    P Navinraja, D Manimaran, R Dinesh, S Sivaramakrishnan, S Velavan
    Indian Journal of Applied Research 5 (7), 579-583 (2015) , 2015
    2015
    Citations: 6
  • “Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type”
    MD Vasan Palanisamy., Namasivayam Elangovan
    Jordan Journal of Pharmaceutical Sciences 17 (4), 783–793 , 2024
    2024
    Citations: 4
  • Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Acute Kidney Injury in Snake Bites Victims
    S Senthilkumaran, D Manimaran, P Thirumalaikolundusubramanian, ...
    International Journal of Theoretical & Applied Sciences, 9 (2), 178-180 (2017) , 2017
    2017
    Citations: 4
  • Synthesis, characterization and potential studies of peptide loaded chitosan coated (PLCC) and sodium alginate (SA) nanoparticles
    D Manimaran, V Palanisamy
    J Clin Chem Lab Med 7, 291 , 2024
    2024
    Citations: 3
  • Current Perspectives in Detection of Bioactive Compounds From Costus spicatus Through GC–MS and LC‐MS/MS: Antioxidant Properties and In Silico Analysis for …
    D Manimaran, A Tessema, MG Yadav, S Parthasarathi, V Palanisamy
    Biochemistry Research International 2025 (1), 9599942 , 2025
    2025
    Citations: 2
  • Author Correction: Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein
    T Mohankumar, V Chandramohan, HS Lalithamba, RL Jayaraj, ...
    Scientific Reports 10, 5085 , 2020
    2020
    Citations: 2
  • A Novel Peptide HIF9-Nano Complex Targeting Apoptosis in Breast Cancer Cells via Modulating HIF Alpha Signaling Cascades
    D Manimaran, V Palanisamy, K Rangasamy, N Elangovan
    International Journal of Peptide Research and Therapeutics 31 (2), 15 , 2025
    2025
    Citations: 1
  • Embryonic Exposure to Sunset Yellow Induce Developmental Alterations and Oxidative Stress in Zebra Fish
    VPNE Dharmar Manimaran, C. Sivagami
    IOASD Journal of Medical and Pharmaceutical Sciences 1 (1), 85-92 , 2024
    2024
    Citations: 1
  • PIASA, A Novel Peptide, Prevents SH-SY5Y Neuroblastoma Cells against Rotenone-induced Toxicity
    AS Sulthana, R Balakrishnan, M Renuka, T Mohankumar, D Manimaran, ...
    Current molecular pharmacology , 2022
    2022
    Citations: 1
  • Exposure to 7, 8 Dihydroxycoumarin protects Cadmium induced toxicity effect in Zebrafish (Daniorerio) embryos
    KGNE Dharmar Manimaran, Varatharajan Renuka , Saravanan Ramesh
    Research Journal of Chemistry and Environment 26 (2), 14-22 , 2022
    2022
    Citations: 1
  • AUTHOR CORRECTION: DESIGN AND MOLECULAR DYNAMIC INVESTIGATIONS OF 7, 8-DIHYDROXYFLAVONE DERIVATIVES AS POTENTIAL NEUROPROTECTIVE AGENTS AGAINST ALPHA-SYNUCLEIN (SCIENTIFIC …
    M Thangavel, B RANGASAMY, M DHARMAR, E NAMASIVAYAM, ...
    SCIENTIFIC REPORTS 10 (1), 5085 , 2020
    2020
    Citations: 1